Oxford Cancer Analytics

Oxford Cancer Analytics Ltd (OXcan) is on a mission to enable curative cancer treatments through early detection. OXcans machine learning platform enables minimally invasive and inexpensive cancer screening in high risk populations through analysing cancer materials shed into the blood. OXcan hopes to create a paradigm shift in screening and eventually replacing invasive tissue biopsy and expensive, complex imaging as the current standard of care. It is safer, cheaper, and detects cancers much earlier, when they are still curable

Oncology,biotechnology,machine learning,cancer detection,liquid biopsy,and r&d

Oxford cancer analytics operates in the Biotechnology industry.

Oxford cancer analytics's revenue is 11m - 100m

Oxford cancer analytics has 11 - 50 employees.